University of Adelaide research has provided new hope for the early detection of stomach cancer with the identification of four new biomarkers in the blood of human cancer patients.
Stomach or gastric cancer is the fourth most common cancer in the world and the second leading cause of death due to cancer.
"Stomach cancer is typically without symptoms in the early stages so most cancers are not diagnosed until the later stages, and the survival rates are therefore low," says Associate Professor Peter Hoffmann, project leader and Director of the University's Adelaide Proteomics Centre.
"Endoscopic investigations are invasive and expensive and most are generally not conducted until the cancer is at an advanced stage.
"A non-invasive, inexpensive screening technique through a simple blood test for the early detection of stomach cancer would make a huge difference in the survival outcomes for people with this disease."